BTN3A3 Downregulation Across Multiple Cancers Points to Potential Metastatic Biomarker
A transcriptomic analysis reveals that immune protein BTN3A3 is consistently downregulated across multiple cancers, highlighting its potential as a metastatic ...
A transcriptomic analysis reveals that immune protein BTN3A3 is consistently downregulated across multiple cancers, highlighting its potential as a metastatic ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.